within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02A_CorticosteroidsForSystemicUsePlain.H02AB10_Cortisone;

model Cortisone
  extends Pharmacolibrary.Drugs.ATC.H.H02AB10;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>H02AB10</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Cortisone is a naturally occurring corticosteroid hormone (glucocorticoid) produced by the adrenal cortex. It is used as a replacement therapy for adrenocortical insufficiency (such as Addison's disease) and historically was used for its anti-inflammatory and immunosuppressive properties. Over time, its clinical use has largely been replaced by other synthetic corticosteroids with more favorable pharmacokinetics. It is not commonly used as a first-line therapy today.</p><h4>Pharmacokinetics</h4><p>Typical pharmacokinetic parameters estimated for an average adult without specific disease conditions, based on general glucocorticoid pharmacology due to limited direct clinical PK data for cortisone.</p><h4>References</h4><ol><li><p>Giordano, R, et al., &amp; Arvat, E (2014). Dual-release Hydrocortisone in Addison&#x27;s Disease - A Review of the Literature. <i>European endocrinology</i> 10(1) 75–78. DOI:<a href=&quot;https://doi.org/10.17925/EE.2014.10.01.75&quot;>10.17925/EE.2014.10.01.75</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/29872468/&quot;>https://pubmed.ncbi.nlm.nih.gov/29872468</a></p></li><li><p>Perogamvros, I, et al., &amp; Ray, DW (2011). Corticosteroid-binding globulin regulates cortisol pharmacokinetics. <i>Clinical endocrinology</i> 74(1) 30–36. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2265.2010.03897.x&quot;>10.1111/j.1365-2265.2010.03897.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/21054475/&quot;>https://pubmed.ncbi.nlm.nih.gov/21054475</a></p></li><li><p>Heazelwood, VJ, et al., &amp; Mortimer, RH (1984). Plasma cortisol delivery from oral cortisol and cortisone acetate: relative bioavailability. <i>British journal of clinical pharmacology</i> 17(1) 55–59. DOI:<a href=&quot;https://doi.org/10.1111/j.1365-2125.1984.tb04999.x&quot;>10.1111/j.1365-2125.1984.tb04999.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/6691888/&quot;>https://pubmed.ncbi.nlm.nih.gov/6691888</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Cortisone;
